Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucienne Ronco

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Muscle & Nerve|May 19, 2022
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatabilityPer Widholm, André Ahlgren, Markus Karlsson, et al.
British Journal of Clinical Pharmacology|May 1, 2021
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagementMichelle L Mellion, Lucienne Ronco, Cecile L Berends, et al.
Neurology|June 24, 2022
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional AnalysisMichelle L Mellion, Per Widholm, Markus Karlsson, et al.
Molecular Cell|August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisGabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Journal of Medicinal Chemistry|September 9, 2011
Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agentMaria-Elena Theoclitou, Brian Aquila, Michael H Block, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemicMaria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Cell|July 27, 2019
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse ProteinopathyMoran Dvela-Levitt, Maria Kost-Alimova, Maheswarareddy Emani, et al.
The Lancet. Neurology|April 17, 2024
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trialRabi Tawil, Kathryn R Wagner, Johanna I Hamel, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Muscle & Nerve|May 19, 2022
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatabilityPer Widholm, André Ahlgren, Markus Karlsson, et al.
British Journal of Clinical Pharmacology|May 1, 2021
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagementMichelle L Mellion, Lucienne Ronco, Cecile L Berends, et al.
Neurology|June 24, 2022
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional AnalysisMichelle L Mellion, Per Widholm, Markus Karlsson, et al.
Molecular Cell|August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisGabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Journal of Medicinal Chemistry|September 9, 2011
Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agentMaria-Elena Theoclitou, Brian Aquila, Michael H Block, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemicMaria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Cell|July 27, 2019
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse ProteinopathyMoran Dvela-Levitt, Maria Kost-Alimova, Maheswarareddy Emani, et al.
The Lancet. Neurology|April 17, 2024
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trialRabi Tawil, Kathryn R Wagner, Johanna I Hamel, et al.
Pageof 2